The Lancet Commission on diabetes: using data to transform diabetes care and patient lives.
By J. Chan, L. Lim, Nick Wareham, J. Shaw, T. Orchard, Ping Zhang, E. Lau, B. Eliasson, A. Kong, M. Ezzati and 34 more. The Lancet, 2020
616 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Genetics
View Paper: https://www.semanticscholar.org/paper/a080701394fee97e3107d90360c4804b1d5fbd88
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
In Genetics
Citations in the corpus
- Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 (2024, background): “…the minimum risk level of exposure required more careful analysis because extrapolating the risk function outside the range of where the available literature supports the protective effect could lead to both exaggerated estimates of attributable burden and implausible levels of consumption.”
- IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045 (2021, positive): “[2–3] The aim of the 10th edition of the IDF Diabetes Atlas is to provide updated estimates and projections of diabetes prevalence as well as health expenditure due to diabetes at national, regional, and global levels.”
- Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2022, neutral): “These principles are aligned with recommendations outlined in the recent Lancet Commission on diabetes [339].”